Maxim has begun coverage on Semler Scientific (SMLR, Financial), assigning a Buy rating to the stock. The firm's analysts have set a price target of $95, suggesting potential growth for the company. This move indicates confidence in Semler Scientific's prospects and future performance in the market.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Semler Scientific Inc (SMLR, Financial) is $101.00 with a high estimate of $101.00 and a low estimate of $101.00. The average target implies an upside of 142.15% from the current price of $41.71. More detailed estimate data can be found on the Semler Scientific Inc (SMLR) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Semler Scientific Inc's (SMLR, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
SMLR Key Business Developments
Release Date: May 13, 2025
- Total Revenue: $8.8 million in Q1 2025, down 44% compared to Q1 2024.
- Operating Expenses: $39.9 million in Q1 2025, including a $29.8 million contingency reserve for DOJ settlement.
- Loss from Operations: $31.1 million in Q1 2025, compared to income from operations of $7 million in Q1 2024.
- Net Loss: $64.7 million or $6.74 per share in Q1 2025, compared to net income of $6.1 million or $0.88 per share in Q1 2024.
- Bitcoin Holdings: 3,808 bitcoins valued at approximately $400 million, with a net unrealized fair value gain of $59 million.
- Cash, Cash Equivalents, and Restricted Cash: $9.9 million as of March 31, 2025.
- Convertible Note Financing: $100 million raised in Q1 2025, primarily used for bitcoin purchases.
- ATM Program: $500 million program effective April 22, 2025, with $61 million raised through May 12.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
- Semler Scientific Inc (SMLR, Financial) has successfully acquired 3,808 bitcoins, valued at approximately $400 million, making it the fourth largest bitcoin treasury company in the US.
- The company achieved a 152.8% positive bitcoin yield since adopting bitcoin as its primary treasury reserve asset, resulting in significant gains.
- Semler Scientific Inc (SMLR) has ambitious plans to further increase its bitcoin holdings with a new $500 million ATM program.
- The company is diversifying its customer base and introducing additional FDA-cleared products in the cardiovascular space, which shows potential for future growth.
- Despite challenges, the company's stock has appreciated 64% in less than 12 months, outperforming the S&P 500's 9% increase.
Negative Points
- Total revenues in Q1 2025 were $8.8 million, down about 44% compared to the first quarter of 2024.
- Operating expenses in Q1 2025 increased significantly to $39.9 million, including a $29.8 million contingency reserve related to a DOJ settlement.
- The company reported a net loss of $64.7 million for Q1 2025, compared to a net income of $6.1 million in Q1 2024.
- There was a net unrealized loss of $41.8 million from the change in fair value of bitcoin holdings, introducing volatility to reported net income.
- The healthcare business faced pressure from CMS payment changes, impacting revenue and requiring strategic adjustments to maintain operations.
